Biological risk based on preoperative serum CA19-9 and histology grade
predicts prognosis in patients with pancreatic cancer
Abstract
Background: Preoperative serum CA19-9 and histology grade could
reflect the biological characteristics of pancreatic ductal
adenocarcinoma (PDAC). This study aims to explore the combined effect of
preoperative CA19-9 and histology grade on the prognosis of patients
with PDAC. Methods: A total of 612 patients with PDAC
undergoing curative pancreatectomy were retrospectively enrolled. A
biological risk model was established based on preoperative CA19-9 and
histology grade. Prognostic significance of the biological risk was
evaluated. Results: 360 (58.8%) patients had preoperative
CA19-9>112 U/ml and 348 (56.9%) patients had high
histology grade. Biological risk based on preoperative CA19-9 and
histology grade was independently associated with survival of PDAC
patients. The biological risk was incorporated into the eighth edition
of the TNM staging system and a modified TNM (mTNM) staging system was
developed. The ROC curves showed that the area under curve(AUC) of the
mTNM staging system was significantly greater than that of the TNM
staging system. Conclusion: Biological risk based on
preoperative CA19-9 and histology grade was an independent prognostic
factors for patients with PDAC. Incorporating the biological risk into
the TNM staging system could improve the the accuracy of the TNM staging
system in predicting prognosis of PDAC.